Providing a new standard-of-care in coagulation diagnostics.
Modernized coagulation testing that can characterize patient physiological data such as anticoagulants, ethnicity and care history. Existing tests such as PT/INR do not provide the sensitivity or depth of information needed in critical care applications such as traumatic injury or surgical monitoring.
Simple to use, mobile and inexpensive; iFirst’s “mobile lab” will enable lifesaving information to be transmitted to the hospital prior to patient arrival. Blood products can be selected as the patient is en-route.
iFirst envisions the growth of products using a mobile health diagnostic platform and continues to pursue its application for other critical situations; where ease of use, cost, and mobility can help save lives of patients and provide care-providers increase profits.
Company’s Keywords:
<4
<
<2016
Your request has been submitted successfully.
Own or work here?